Kaijin Yao
Overview
Explore the profile of Kaijin Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yao K, Zheng L, Chen W, Xie Y, Liao C, Zhou T
Front Immunol
. 2025 Feb;
16:1438683.
PMID: 39981255
Immunoglobulin A nephropathy (IgAN) is the most prevalent glomerulonephritis in the world, and it is one of the leading causes of end-stage kidney disease. It is now believed that the...
2.
Zheng L, Chen W, Yao K, Xie Y, Liao C, Lin Y, et al.
Ren Fail
. 2024 Dec;
46(2):2438863.
PMID: 39681477
Background: Peritoneal fibrosis is a serious complication of long-term peritoneal dialysis, often resulting in functional deterioration and withdrawal from therapy. Mesenchymal stem cells (MSCs) have demonstrated immunomodulatory and antifibrotic effects...
3.
Xie Y, Zheng L, Chen W, Zeng Y, Yao K, Zhou T
Curr Pharm Des
. 2024 Sep;
31(2):83-94.
PMID: 39257144
Oxidative stress is a biological stress response produced by the destruction of redox equilibrium in aerobic metabolism in organisms, which is closely related to the occurrence of many diseases. Mesenchymal...
4.
Zheng L, Chen W, Yao K, Xie Y, Liao C, Zhou T
Stem Cell Res Ther
. 2024 Jul;
15(1):237.
PMID: 39080683
Peritoneal dialysis is an important part of end-stage kidney disease replacement therapy. However, prolonged peritoneal dialysis can result in peritoneal fibrosis and ultrafiltration failure, forcing patients to withdraw from peritoneal...
5.
Chen Z, Chen W, Zheng L, Xie Y, Yao K, Zhou T
Curr Pharm Des
. 2024 Jul;
30(30):2400-2409.
PMID: 38988169
Introduction And Aim: Immunoglobulin A nephropathy (IgAN), characterized by aberrant IgA immune complex deposition, is the most prevalent primary glomerular disease and the main cause of end-stage renal disease, causing...
6.
Chen Z, Lin Y, Wang J, Yao K, Xie Y, Chen X, et al.
Curr Pharm Des
. 2024 Mar;
30(8):589-596.
PMID: 38477209
Chronic kidney disease (CKD) refers to the presence of structural or functional abnormalities in the kidneys that affect health, lasting for more than 3 months. CKD is not only the...
7.
Chen X, Wang J, Lin Y, Yao K, Xie Y, Zhou T
Front Endocrinol (Lausanne)
. 2023 Dec;
14:1236404.
PMID: 38047108
Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors provide cardiovascular protection for patients with heart failure (HF) and type 2 diabetes mellitus (T2DM). However, there is little evidence of their application in...
8.
Zhou T, Yao K, Xie Y, Lin Y, Wang J, Chen X
Curr Pharm Des
. 2023 Aug;
29(21):1659-1670.
PMID: 37537933
Introduction: Chronic kidney disease (CKD) has a clinical characteristic of progressive loss of kidney function and becomes a serious health and social concern. SGLT2i (sodium-glucose cotransporter 2 inhibitors), a class...
9.
Yao K, Xie Y, Wang J, Lin Y, Chen X, Zhou T
Front Immunol
. 2023 Aug;
14:1202850.
PMID: 37533870
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominantly affects women of childbearing age and is characterized by the damage to multiple target organs. The pathogenesis of SLE...